A detailed lectin analysis of IgG glycosylation, demonstrating disease specific changes in terminal galactose and N-acetylglucosamine

被引:76
作者
Bond, A
Alavi, A
Axford, JS
Bourke, BE
Bruckner, FE
Kerr, MA
Maxwell, JD
Tweed, KJ
Weldon, MJ
Youinou, P
Hay, FC
机构
[1] ST GEORGE HOSP, SCH MED, ACAD RHEUMATOL UNIT, LONDON SW17 0RE, ENGLAND
[2] ST GEORGE HOSP, DEPT RHEUMATOL, LONDON, ENGLAND
[3] UNIV DUNDEE, NINEWELLS HOSP & MED SCH, DEPT PATHOL, DUNDEE DD1 9SY, SCOTLAND
[4] ST GEORGE HOSP, SCH MED, DEPT BIOCHEM MED, LONDON, ENGLAND
[5] CTR HOSP REG, IMMUNOL LAB, BREST, BELARUS
[6] UNIV BREST, BREST, BELARUS
关键词
rheumatoid arthritis; juvenile onset chronic arthritis; Crohn's disease; infectious endocarditis; Sjogren's syndrome; SLE; ankylosing spondylitis; ulcerative colitis; osteoarthritis; IgG glycosylation; galactose; N-acetylglucosamine;
D O I
10.1006/jaut.1996.0104
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Serum IgG from rheumatoid arthritis patients contains a decreased number of oligosaccharide structures ending in galactose and thus there is an increase in N-acetylglucosamine as the terminal sugar, compared with healthy individuals. The relationship between these two sugars varies depending on the disease examined: IgG from patients with rheumatoid arthritis, juvenile onset chronic arthritis and Crohn's disease are at one extreme, and exhibit a reciprocal galactose:N-acetylglucosamine relationship, while Sjogren's syndrome and osteoarthritis IgG are at the other extreme, exhibiting a parallel increase in the expression of both galactose and N-acetylglucosamine. These results may occur as a consequence of more than one glycosylation site which is differentially glycosylated, but more likely by changes in the level of bisecting N-Acetylglucosamine. (C) 1997 Academic Press Limited.
引用
收藏
页码:77 / 85
页数:9
相关论文
共 36 条
[1]  
ALAVI A, 1996, ABNORMALITIES IGG GL, P149
[2]   THE AMERICAN-RHEUMATISM-ASSOCIATION 1987 REVISED CRITERIA FOR THE CLASSIFICATION OF RHEUMATOID-ARTHRITIS [J].
ARNETT, FC ;
EDWORTHY, SM ;
BLOCH, DA ;
MCSHANE, DJ ;
FRIES, JF ;
COOPER, NS ;
HEALEY, LA ;
KAPLAN, SR ;
LIANG, MH ;
LUTHRA, HS ;
MEDSGER, TA ;
MITCHELL, DM ;
NEUSTADT, DH ;
PINALS, RS ;
SCHALLER, JG ;
SHARP, JT ;
WILDER, RL ;
HUNDER, GG .
ARTHRITIS AND RHEUMATISM, 1988, 31 (03) :315-324
[3]  
AXFORD JS, 1994, J RHEUMATOL, V21, P1791
[4]   CHANGES IN NORMAL GLYCOSYLATION MECHANISMS IN AUTOIMMUNE RHEUMATIC DISEASE [J].
AXFORD, JS ;
SUMAR, N ;
ALAVI, A ;
ISENBERG, DA ;
YOUNG, A ;
BODMAN, KB ;
ROITT, IM .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 89 (03) :1021-1031
[5]  
Bennett P.H., 1967, B RHEUM DIS, V17, P453
[6]  
BEST WR, 1976, GASTROENTEROLOGY, V70, P439
[7]  
BLAND M, 1995, INTRO MED STAT, P175
[8]   HUMAN-IGG PREPARATIONS ISOLATED BY ION-EXCHANGE OR PROTEIN-G AFFINITY-CHROMATOGRAPHY DIFFER IN THEIR GLYCOSYLATION PROFILES [J].
BOND, A ;
JONES, MG ;
HAY, FC .
JOURNAL OF IMMUNOLOGICAL METHODS, 1993, 166 (01) :27-33
[9]   GLYCOSYLATION OF IGG, IMMUNE-COMPLEXES AND IGG SUBCLASSES IN THE MRL-LPR/LPR MOUSE MODEL OF RHEUMATOID-ARTHRITIS [J].
BOND, A ;
COOKE, A ;
HAY, FC .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1990, 20 (10) :2229-2233
[10]   The relationship between exposed galactose and N-acetylglucosamine residues on IgG in rheumatoid arthritis (RA), juvenile chronic arthritis (JCA) and Sjogren's syndrome (SS) [J].
Bond, A ;
Alavi, A ;
Axford, JS ;
Youinou, P ;
Hay, FC .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1996, 105 (01) :99-103